NCT03241381

Brief Summary

Melasma is a commonly pigmention characterized by melanotic patches on the face. literature searched revealed that periodontitis and vitamin D deficiency have occurred along with anemia. Actinic associated factors may be indirectly related to vitamin D, melasma contributes to sun exposed area of face.To correlate melasma with clinical evidence of periodontitis and vitamin D serum analysis along side hb %. Patients with facial melasma between 30-70yrs of either gender formed Group A (95). Anaemia and periodontitis were Clinically checked. Additionally serum analysis of vitamin D and hb percentage were analysed. Similar procedure was carried out on controls which had Group B (95) patients with no melasma on face. The study revealed significant correlation between melasma and periodontitis with vitamin D abnormalities (p value\<.05), where as insignificant correlation between melasma and Hb%. The correlation between melasma, vitamin d changes and periodontitis may prompt the clinician to check for any such changes in any patient. Melasma in patients with periodontitis and serum vitamin D changes might be a considered as a syndrome.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2016

Shorter than P25 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2016

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2017

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

August 2, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 7, 2017

Completed
Last Updated

December 19, 2017

Status Verified

December 1, 2017

Enrollment Period

10 months

First QC Date

August 2, 2017

Last Update Submit

December 18, 2017

Conditions

Keywords

observational sample

Outcome Measures

Primary Outcomes (3)

  • Serum Vitamin D analysis

    I. The criteria for serum vitamin D analysis was followed which was laid by NATIONAL INSTITUTE OF HEALTH vitamin D fact sheet (2011) in both the groups using chemilumnescence method. \<12 ng/ml -significant deficiency 12- 20 ng/ml - insufficiency \>20 ng/ml - normal \> 50 ng/ml - hypervitaminosis

    3 -4 days

  • Serum- hemoglobin levels

    Evidence of pallor was checked clinically by examination of palpebral conjunctiva and correlated with serum haemoglobin percentage in both the groups using photometry method.

    1 day

  • Clinical Periodontal index

    The criteria to diagnose periodontitis clinically was followed by regulations laid down by Russell's periodontal index status , using mouth mirror and plain probe on all the gingival tissue circumscribing each tooth. It was assessed for gingival inflammation and periodontal involvement with loss of attachment. The evaluation was done by only one specialist.

    1 day

Study Arms (2)

Group A : Melasma

patients with facial pigmentation in the form of melasma

Diagnostic Test: vitamin D serum assay study and control groupsDiagnostic Test: PhotometryOther: Russels periodontal index

Group B: Non Melasma

Patients without any facial pigmentation or melasma

Diagnostic Test: vitamin D serum assay study and control groupsDiagnostic Test: PhotometryOther: Russels periodontal index

Interventions

Serum- vitamin D assay

Group A : MelasmaGroup B: Non Melasma
PhotometryDIAGNOSTIC_TEST

Serum- Hemoglobin assay

Group A : MelasmaGroup B: Non Melasma

Clinical examination for periodontitis

Group A : MelasmaGroup B: Non Melasma

Eligibility Criteria

Age30 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Total number of 100 patients participated in the study, 50 in each group. Patients visiting the Dept. of Oral medicine, with melasma on face within the age group of 30-70yrs in either gender were included in the study, matched with similar control group without melasma after obtaining informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

MelanosisPeriodontitisAnemia

Condition Hierarchy (Ancestors)

HyperpigmentationPigmentation DisordersSkin DiseasesSkin and Connective Tissue DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesHematologic DiseasesHemic and Lymphatic Diseases

Study Officials

  • NALLAN Ck CHAITANYA, mds

    Panineeya Institute of dental sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, department of oral medicine and radiology

Study Record Dates

First Submitted

August 2, 2017

First Posted

August 7, 2017

Study Start

October 1, 2016

Primary Completion

August 1, 2017

Study Completion

August 1, 2017

Last Updated

December 19, 2017

Record last verified: 2017-12

Data Sharing

IPD Sharing
Will not share